References
- Adé A, Chauchat L, Frève JO, Gagné S, Caron N, Bussières J-F. 2017. Comparison of decontamination efficacy of cleaning solutions on a biological safety cabinet workbench contaminated by cyclophosphamide. Can J Hosp Pharm. 70(6):407–414. doi:https://doi.org/10.4212/cjhp.v70i6.1708
- Anastasi M, Rudaz S, Queruau Lamerie T, Odou P, Bonnabry P, Fleury-Souverain S. 2015. Efficacy of two cleaning solutions for the decontamination of 10 antineoplastic agents in the biosafety cabinets of a hospital pharmacy. Ann Occup Hyg. 59(7):895–908. doi:https://doi.org/10.1093/annhyg/mev031
- Barek J, Cvacka J, de Méo M, Laget M, Michelon J, Castegnaro M. 1998. Chemical degradation of wastes of antineoplastic agents amsacrine, azathioprine, asparaginase and thiotepa. Ann Occup Hyg. 42(4):259–266. doi:https://doi.org/10.1016/s0003-4878(98)00023-4
- Bobin-Dubigeon C, Amiand M, Percheron C, Audeval C, Rochard S, Leynia P, Bard JM. 2013. A new, validated wipe-sampling procedure coupled to LC-MS analysis for the simultaneous determination of 5-fluorouracil, doxorubicin and cyclophosphamide in surface contamination. J Anal Toxicol. 37(7):433–439. doi:https://doi.org/10.1093/jat/bkt045
- Böhlandt A, Groeneveld S, Fischer E, Schierl R. 2015. Cleaning efficiencies of three cleaning agents on four different surfaces after contamination by gemcitabine and 5-fluorouracile. J Occup Environ Hyg. 12(6):384–392. doi:https://doi.org/10.1080/15459624.2015.1009985
- Chauchat L, Tanguay C, Caron NJ, Gagné S, Labrèche F, Bussières JF. 2019. Surface contamination with ten antineoplastic drugs in 83 Canadian centers. J Oncol Pharm Pract. 25(5):1089–1098. doi:https://doi.org/10.1177/1078155218773862
- Colombo M, Jeronimo M, Astrakianakis G, Apte C, Hon CY. 2017. Wipe sampling method and evaluation of environmental variables for assessing surface contamination of 10 AD by liquid chromatography/tandem mass spectrometry. Ann Work Expo Health. 61(8):1003–1014. doi:https://doi.org/10.1093/annweh/wxx070
- Connor TH, DeBord DG, Pretty JR, Oliver MS, Roth TS, Lees PS, Krieg EF, Jr, Rogers B, Escalante CP, Toennis CA, et al. 2010. Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med. 52(10):1019–1027. doi:https://doi.org/10.1097/JOM.0b013e3181f72b63
- Connor TH, McDiarmid MA. 2006. Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J Clin. 56(6):354–365. doi:https://doi.org/10.3322/canjclin.56.6.354
- Crul M, Simons-Sanders K. 2018. Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies. J Oncol Pharm Pract. 24(7):483–489. doi:https://doi.org/10.1177/1078155217704990
- Dal Bello F, Santoro V, Scarpino V, Martano C, Aigotti R, Chiappa A, Davoli E, Medana C. 2016. Antineoplastic drug determination by HPLC-HRMS(n) to monitor occupational exposure. Drug Test Anal. 8(7):730–737. doi:https://doi.org/10.1002/dta.1827
- Dugheri S, Bonari A, Pompilio I, Boccalon P, Mucci N, Arcangeli G. 2018a. A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments. Arh Hig Rada Toksikol. 69(3):226–237. doi:https://doi.org/10.2478/aiht-2018-69-3125
- Dugheri S, Bonari A, Pompilio I, Boccalon P, Tognoni D, Cecchi M, Ughi M, Mucci N, Arcangeli G. 2018b. Analytical strategies for assessing occupational exposure to antineoplastic drugs in healthcare workplaces. Med Pr. 69(6):589–604. doi:https://doi.org/10.13075/mp.5893.00724
- Fransman W, Vermeulen R, Kromhout H. 2005. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health. 78(5):403–412. doi:https://doi.org/10.1007/s00420-004-0595-1
- Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Galichet L, Cogliano V. 2009. A review of human carcinogens-part A: pharmaceuticals. WHO International Agency for Research on Cancer Monograph Working Group. Lancet Oncol. 10(1):13–14. doi:https://doi.org/10.1016/S1470-2045(08)70286-9
- Hedmer M, Jönsson BAG, Nygren O. 2004. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. J Environ Monit. 6(12):979–984. doi:https://doi.org/10.1039/b409277e
- Hedmer M, Tinnerberg H, Axmon A, Jönsson BAG. 2008. Environmental and biological monitoring of AD in four workplaces in a Swedish hospital. Int Arch Occup Environ Health. 81(7):899–911. doi:https://doi.org/10.1007/s00420-007-0284-y
- Hedmer M, Wohlfart G. 2012. Hygienic guidance values for wipe sampling of AD in Swedish hospitals. J Environ Monit. 14(7):1968–1975. doi:https://doi.org/10.1039/c2em10704j
- Hetzel T, Vom Eyser C, Tuerk J, Teutenberg T, Schmidt TC. 2016. Micro-liquid chromatography mass spectrometry for the analysis of antineoplastic drugs from wipe samples. Anal Bioanal Chem. 408(28):8221–8229. doi:https://doi.org/10.1007/s00216-016-9932-y
- Hon CY, Teschke K, Shen H, Demers PA, Venners S. 2015. Antineoplastic drug contamination in the urine of Canadian healthcare workers. Int Arch Occup Environ Health. 88(7):933–941. doi:https://doi.org/10.1007/s00420-015-1026-1
- Jeronimo M, Colombo M, Astrakianakis G, Hon C-Y. 2015. A surface wipe sampling and LC-MS/MS method for the simultaneous detection of six AD commonly handled by healthcare workers. Anal Bioanal Chem. 407(23):7083–7092. doi:https://doi.org/10.1007/s00216-015-8868-y
- Jeronimo M, Arnold S, Astrakianakis G, Lyden G, Stewart Q, Petersen A, Chambers C, Malard Johnson D, Zimdars E, Kaup H, et al. 2021. Spatial and temporal variability in antineoplastic drug surface contamination in cancer care centers in Alberta and Minnesota. Ann Work Expo Health. 2021:1–15.
- Kiffmeyer TK, Tuerk J, Hahn M, Stuetzer H, Hadtstein C, Heinemann A, Eickmann U. 2013. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies—the MEWIP project. Ann Occup Hyg. 57(4):444–455. doi:https://doi.org/10.1093/annhyg/mes081
- Kromhout H. 2016. Hygiene without numbers. Ann Occup Hyg. 60(4):403–404. doi:https://doi.org/10.1093/annhyg/mev096
- Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars RF, Anzion R, Vermeulen R. 2000. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg. 44(7):551–560. doi:https://doi.org/10.1016/s0003-4878(00)00050-8
- Maeda S, Miwa Y. 2013. Multicomponent high-performance liquid chromatography/tandem mass spectrometry analysis of ten chemotherapeutic drugs in wipe samples. J Chromatogr B Analyt Technol Biomed Life Sci. 921–922:43–48.
- Merger D, Tanguay C, Langlois E, Lefebvre M, Bussières JF. 2014. Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals. Int Arch Occup Environ Health. 87(3):307–313. doi:https://doi.org/10.1007/s00420-013-0862-0
- NIOSH. 2016. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. By Connor TH, MacKenzie BA, DeBord DG, Trout DB, O’Callaghan JP, Cincinnati OH. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication Number 2016–2161.
- Nussbaumer S, Geiser L, Sadeghipour F, Hochstrasser D, Bonnabry P, Veuthey J-L, Fleury-Souverain S. 2012. Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces. Anal Bioanal Chem. 402(8):2499–2509. doi:https://doi.org/10.1007/s00216-011-5157-2
- Palamini M, Floutier M, Gagné S, Caron N, Bussières JF. 2021. Evaluation of decontamination efficacy of four antineoplastics (ifosfamide, 5-fluorouracil, irinotecan, and methotrexate) after deliberate contamination. J Occup Environ Hyg. 18(2):43–50. doi:https://doi.org/10.1080/15459624.2020.1854458
- Pretty JR, Connor TH, Spasojevic I, Kurtz KS, McLaurin JL, B’Hymer C, Debord DG. 2012. Sampling and mass spectrometric analytical methods for five AD in the healthcare environment. J Oncol Pharm Pract. 18(1):23–36. doi:https://doi.org/10.1177/1078155210389215
- Queruau Lamerie T, Nussbaumer S, Décaudin B, Fleury-Souverain S, Goossens J-F, Bonnabry P, Odou P. 2013. Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents. Ann Occup Hyg. 57(4):456–469. doi:https://doi.org/10.1093/annhyg/mes087
- Rossignol E, Amiand MB, Sorrieul J, Bard JM, Bobin-Dubigeon C. 2020. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics. J Pharmacol Toxicol Methods. 101:106652. doi:https://doi.org/10.1016/j.vascn.2019.106652
- Schierl R, Böhlandt A, Nowak D. 2009. Guidance values for surface monitoring of AD in German pharmacies. Ann Occup Hyg. 53(7):703–711.
- Sottani C, Grignani E, Oddone E, Dezza B, Negri S, Villani S, Cottica D. 2017. Monitoring surface contamination by antineoplastic drugs in Italian hospitals: performance-based Hygienic Guidance Values (HGVs) project. Ann Work Expo Health. 61 (8):994–1002. doi:https://doi.org/10.1093/annweh/wxx065
- Tuerk J, Kiffmeyer TK, Hadtstein C, Heinemann A, Hahn M, Stuetzer H, Kuss HM, Eickmann U. 2011. Development and validation of an LC–MS/MS procedure for environmental monitoring of eight cytostatic drugs in pharmacies. Int J Environ Anal Chem. 91(12):1178–1190. doi:https://doi.org/10.1080/03067319.2010.494769